Latest Rovi News & Updates

See the latest news and media coverage for Rovi. We track all announcements, press releases, and industry mentions in real time, all in one place.

Rovi

Specialized pharmaceutical company researching, manufacturing, and commercializing medicines

rovi.es

Headquarters: Madrid, Spain
Founded year: 1946
Company type: Private company
Number of employees: 1,200–5,000
Industry: Pharmaceuticals

Last updated October 16

Latest news about Rovi

In short: Rovi posted strong H1 2026 results amid US plant acquisition, Roche pact, and Q1 profit-led share falls.

Company announcements

July 21 Rovi

Rovi reports H1 2026 results with strong financial growth

Operating revenue reached €344.2 million, up 9%. Net profit increased by 113% to €84.4 million due to a bargain purchase gain from a Phoenix facility acquisition.

June 5 Rovi

Rovi reports Q1 2026 financial results showing net profit of 9.4 million euros

The company completed its Phoenix acquisition and updated 2026 guidance amid heparin sales declines.

May 6 Rovi

Laboratorios ROVI publishes 1Q 2026 results

Operating income reaches 152.5 million euros. CDMO grows 5%, Risperidona ISM® 37%. R&D investment rises 79% to 11.2 million.

May 6 Rovi

Rovi reports Q1 2026 revenue of 154.7 million euros

Gross margin expands 3.8 points to 62.3%. Heparin sales drop 12%, Okedi rises 37%. Updates 2026 guidance to low-to-mid single-digit growth. Announces plant acquisition completion.

Media coverage

October 16 MSN

Rovi faces the expiration of its third best-selling drug

Rovi Laboratories faces the expiration of the license agreement for one of the drugs with the greatest commercial weight in its pharmaceutical specialties business. Yesterday...

October 5 Ad Hoc News

Rovi stock gains 1.20 percent as CDMO revenue jumps

According to Yahoo Finance in its July 23, 2026 transcript, total first-half 2026 revenue rose 13 percent to EUR 357 million, while operating revenue increased...

October 4 El Economista

Rovi expands its injectables capacity to double its manufacturing business

Rovi expands the capacity of its industrial network to more than double its third-party production business and reach €700 million...

September 9 Marketscreener

Rovi Pharmaceutical Laboratories, S.A. Shares

23/07 Rovi Pharmaceutical Laboratories S A : Insider Information - The Company makes public the submission regarding the financial results for the first half of...

Never miss news about Rovi

Track Rovi and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Rovi competitors & trending companies

Browse news for competitors to Rovi and other trending companies.